Everhart Financial Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Buy
+2,811
New +$265K 0.01% 459
2025
Q4
Sell
-1,999
Closed -$292K 440
2025
Q3
$292K Sell
1,999
-390
-16% -$59K 0.03% 316
2025
Q2
$373K Buy
2,389
+531
+29% +$84.2K 0.04% 267
2025
Q1
$306K Sell
1,858
-8
-0.4% -$1.33K 0.04% 275
2024
Q4
$304K Sell
1,866
-425
-19% -$76K 0.06% 255
2024
Q3
$448K Buy
2,291
+410
+22% +$75.5K 0.1% 207
2024
Q2
$326K Buy
1,881
+284
+18% +$47.3K 0.08% 215
2024
Q1
$270K Buy
1,597
+295
+23% +$55.3K 0.08% 226
2023
Q4
$257K Sell
1,302
-105
-7% -$18.6K 0.09% 206
2023
Q3
$245K Buy
1,407
+138
+11% +$25.1K 0.1% 179
2023
Q2
$219K Buy
+1,269
New +$219K 0.09% 197
2022
Q4
Sell
-1,668
Closed -$247K 229
2022
Q3
$247K Buy
1,668
+235
+16% +$39.3K 0.14% 151
2022
Q2
$247K Buy
+1,433
New +$248K 0.15% 141

Other funds holding ZTS

Everhart Financial Group's ZTS Position: Q2 2026 in Review

Everhart Financial Group opened a new position in Zoetis (ZTS) in Q2 2026: 2,811 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #459 among its holdings. This is a return to the name: Everhart Financial Group previously reported a position in ZTS as recently as Q3 2025.

Everhart Financial Group first reported a position in ZTS in Q2 2022 and has held it in 13 quarters since. The position peaked at $448K in Q3 2024. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Everhart Financial Group held 2,811 shares of Zoetis worth $202K as of Q2 2026.
  • Zoetis was a new Everhart Financial Group position in Q2 2026.
  • Zoetis made up 0.01% of Everhart Financial Group's portfolio in Q2 2026, its #459 holding.
  • Everhart Financial Group first reported a position in Zoetis in Q2 2022 and has held it in 13 quarters since.
  • Everhart Financial Group's Zoetis position peaked at $448K in Q3 2024.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.